Valencia Catalina's Form 4 filing
Axim Biotechnologies, Inc. (AXIM) · filed Oct 15, 2024
- Accession no.
- 0001096906-24-002004
- Filed
- Oct 15, 2024
- Trade date
- Jan 30, 2024
- Filing delay
- 259 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. It was filed 259 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Valencia CatalinaCIK 0001944813 | Director, Officer (President and Director), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 30, 2024 | Common Stock | PPurchaseAcquired | +1,086,216 | –F1 | – | 28,608,220 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Acquired from third party
Referenced by the price of 1 transaction in Table I.